Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hagens Berman Sobol Shapiro
Hagens Berman Sobol Shapiro: Firm Appointed Lead Counsel in Charles Schwab YieldPlus Class Action
September 7th, 2008
Today United States District Judge William Alsup appointed Hagens Berman Sobol Shapiro lead counsel in the class-action litigation against Charles Schwab Corporation (NASDAQ:SCHW) involving Schwab YieldPlus Funds Investor Shares (SWYSX) and Schwab YieldPlus Funds Select Shares (SWYPX). Hagens Berman Sobol Shapiro filed the first class-action suit against Charles Schwab on March 18, 2008, alleging that Schwab deceived investors about the underlying risk in the funds. The funds were marketed as cash alternative when, in fact, the funds were highly speculative including risky mortgage-related structured debt, the suit contends. After Hagens Berman Sobol...
Source: Pharma Investments, Ventures & Law Weekly (2008-09-07)
|
